Verified Nov 2026
Other
·
Miami Lakes, Florida
·
Since 1957
Cordis is a medical device company that makes minimally invasive cardiovascular and endovascular products, including stents, vascular access devices, guidewires, embolic protection devices, and cardiac mapping equipment. It is headquartered in Miami Lakes, Florida, and was founded in 1957. The company employs between 1,000 and 5,000 people and is privately owned following its 2021 acquisition by Hellman & Friedman. It serves the medical, automotive, electric-vehicle, and industrial equipment sectors. In September 2026, the company announced FDA approval for its SELUTION SLR PTCA drug-eluting balloon.
Cordis at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Founded
1957
Headquarters
Miami Lakes, Florida
Certifications
ISO 13485 · ISO 14001
Import activity
7
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
7
Named foreign suppliers
4
Top origins
Greece · Israel · Spain · China
Shared foreign counterparties do not establish that these companies buy from Cordis.
What this tells a buyer
The record contains no customs or trade shipment data for the company, and its most recent public development is the FDA approval of its SELUTION SLR PTCA drug-eluting balloon reported on cordis.com in September 2026.
The company holds ISO 13485 and ISO 14001 certifications and reports interventional vascular products such as stents, guidewires, and cardiac mapping equipment among its offerings.
Cordis is privately held after being acquired by Hellman & Friedman in August 2021, and it reports revenue in the estimated $500 million to $1 billion range.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
STABILITY SIGNALS
Established & active
69 years in operation (founded 1957).
Holds ISO 13485, ISO 14001 certification(s) per public sources.
Overview
Cordis is a medical device company that makes minimally invasive cardiovascular and endovascular products, including stents, vascular access devices, guidewires, embolic protection devices, and cardiac mapping equipment. It is headquartered in Miami Lakes, Florida, and was founded in 1957. The company employs between 1,000 and 5,000 people and is privately owned following its 2021 acquisition by Hellman & Friedman. It serves the medical, automotive, electric-vehicle, and industrial equipment sectors. In September 2026, the company announced FDA approval for its SELUTION SLR PTCA drug-eluting balloon.
At a glance
Attribute | Detail |
|---|---|
Founded | 1957 |
Headquarters | Miami Lakes, Florida |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
Certifications | ISO 13485 · ISO 14001 |
What Cordis makes
The company holds ISO 13485 and ISO 14001 certifications and reports interventional vascular products such as stents, guidewires, and cardiac mapping equipment among its offerings.
Certifications
Cordis is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — cordis.com
ISO 14001 — industryweek.com
Trade and customs footprint
The record contains no customs or trade shipment data for the company, and its most recent public development is the FDA approval of its SELUTION SLR PTCA drug-eluting balloon reported on cordis.com in September 2026. US customs bill-of-lading records list 7 inbound shipments across 4 foreign suppliers, with top origins including Greece · Israel · Spain · China.
Latest developments
2026-09-21 — Cordis | SELUTION SLR PTCA Drug-Eluting Balloon FDA Approval (cordis.com)
2026-03-17 — Cordis | State of Florida and Cordis Announce Planned Investment (cordis.com)
2026-02-16 — PCI Consumables (Cordis) - Contracts Finder (service.gov.uk)
2026-01-17 — H&F weighs $9 billion-plus sale of medical device maker Cordis, Bloomberg News reports | Reuters (reuters.com)
2025-12-17 — 🏭89,000 SF Manufacturing & Distribution Lease Completed with Cordis Corporation in Miami Lakes 🩺 | Steve Medwin (linkedin.com)
2025-10-07 — HPS to Lead Over $500M Private Credit Deal to Refi Cordis’ Existing BSL Debt (octus.com)
Company details
Cordis is privately held after being acquired by Hellman & Friedman in August 2021, and it reports revenue in the estimated $500 million to $1 billion range. Cordis was founded in 1957, has an estimated 1,000-5,000 employees, and is headquartered in Miami Lakes, Florida. On the LightSource stability read it is rated "Established & active": 69 years in operation (founded 1957). Holds ISO 13485, ISO 14001 certification(s) per public sources.
Frequently asked questions
What does Cordis do?
Cordis is a medical device company that makes minimally invasive cardiovascular and endovascular products, including stents, vascular access devices, guidewires, embolic protection devices, and cardiac mapping equipment. It is headquartered in Miami Lakes, Florida, and was founded in 1957. The company employs between 1,000 and 5,000 people and is privately owned following its 2021 acquisition by Hellman & Friedman. It serves the medical, automotive, electric-vehicle, and industrial equipment sectors. In September 2026, the company announced FDA approval for its SELUTION SLR PTCA drug-eluting balloon.
Where is Cordis headquartered?
Cordis is headquartered in Miami Lakes, Florida.
When was Cordis founded?
Cordis was founded in 1957.
How big is Cordis?
Cordis has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
What certifications does Cordis hold?
Cordis lists ISO 13485 · ISO 14001 on its website. Confirm the certified scope for the specific plant producing your part.
Does Cordis import from overseas suppliers?
US customs bill-of-lading records show 7 inbound shipments for Cordis, with top origins including Greece · Israel · Spain · China.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.